chrisvoncsefalvay/vaers-outcomes huggingface dataset:
01/15/2022 I woke up and had hives where I had my total hip replacement. It would go away and come back and spread to buttocks and arms and that's when I went to the ER. I never had any respiratory symptoms or anything like that. It spread where I had some incisions on abdomen from laparoscopic procedure and it went into my hands later on. In the ER they felt it might've been the lotion I was using so I got some CeraVe and started using that and it didn't help so I went to the Doctor 2 weeks later and that's when he said he felt it was something I was allergic to. I've been using CeraVe and taking medications and it has lessened but it flares up again and again and today is better than it was yesterday. It's been on my back, belly, breasts, legs, arms, and occasionally on my face. They are anywhere from the size of a dime to the size of an egg. I also had some in between legs and they itch and were raised. Some of them, when they are diminished, leave a black and blue mark. I also lost my voice in the last couple of weeks.
pt recv vax DEC95 & pt devel chickenpox w/50 to 100 lesions;
Patient became diaphoretic, pale "gray".  B/P 106/64, P-44, O2 sat- 100% on room air.  Assisted patient to floor elevated legs.  At 10:00am patient states feeling better.  At 10:08am B/P- 115/72, Blood sugar 114.  Patient left at 10:20am.
This spontaneous report as received from a nurse refers to a patient of unknown age and gender. No concurrent conditions, medical history, allergy/drug reactions and concomitant medications were reported. On 07-JUN-2016, the patient was vaccinated with improperly stored ROTATEQ lot# L027076 with expiry date: 25-MAY-2017, Lot# L033545 expiry date: 30-MAY-2017 (lot not specified for each patient) (dosing details and route of administration were not reported). No adverse effect was reported. It was reported that the vaccines were exposed to the temperature 55F for 30 minutes. The previous temperature excursion was 32.9F for 17 hours. There were no product quality complaints (PQC) involved. This is one of several reports received from the same reporter. Additional information has been requested.
I had a reaction at the site of the injection. It was a large, raised reaction that was hard and itchy.
a point of hyperventilation; Breathing started to get rapid; Hands and stomach muscles cramped up as the heart continued to race; Hands and stomach muscles cramped up as the heart continued to race; suddenly both hands started shaking; heart rate increasing, reaching higher than 166; This is a spontaneous report from a contactable consumer (patient). A 14-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EW0179), via an unspecified route of administration, administered in left arm on 12May2021 at 17:00 (at the age of 14-year-old) at single dose for COVID-19 immunization. Medical history and concomitant medications were reported as no. Prior to vaccination, patient was not diagnosed with COVID-19. No known allergy. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. It was reported that 24 hours after the vaccine on 13May2021 at 17:00, while seate, suddenly both hands started shaking followed by heart rate increasing, reaching higher than 166 bpm. Breathing started to get rapid to a point of hyperventilation on 13May2021 at 18:00. Hands and stomach muscles cramped up as the heart continued to race on 13May2021 at 18:00. Called 911 and they were able to decrease the hyperventilation through slowed box breathing. They stayed for about 30 minutes as the heat rate slowly decreased to just over 100 bmp on 13May2021. Two other incidents of increased heat rate have happened since in May2021. Events were resulted in Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. Since the vaccination, patient had not been tested for COVID-19. Therapeutic measures were taken as a result of all events included hydroxyzine prescribed to induce calming effect as. The outcome of events heart rate increasing, hyperventilation and breathing started to get rapid was recovering; outcome of the other events was unknown. This report was reported as non-serious by reporter, with seriousness criteria-Results in death: No; Life threatening: No; Caused/prolonged hospitalization: No; Disabling/Incapacitating: No; Congenital anomaly/birth defect: No.  No follow-up attempts are needed. No further information is expected.
PT HAD A SYNCOPE EPISODE WHEN ADMINISTER HPV VACCINE. PT HAD TDAP/ MCV ON RT ARM PT WAS FINE ONLY COMPLAIN WAS (IT HURTS). WHEN NURSE WAS ADMINISTRATING HPV PT HAD THE SYNCOPE EPISODE. NURSE HOLD PT LAY HER DOWN ON EXAM TABLE. MOM CALL DR. RECHECK PT'S VITALS. LAY DOWN PT FOR 15-30 MIN. ON THE EXAM TABLE. PT FEEL BETTER IN 10 MINUTES. DR RECHECK PT EVERY 5 MINUTES TO MAKE SURE PT WAS FINE. PT RECOVERED AND WAS SEND HOME. AS PER MOM PT HAS HAD SYNCOPE EPISODES WHEN SHE GETS SHOTS OR BLOOD DRAWN.
After receiving  my first shot , within 5 minutes  my feet was numb and tingling . This lasted for 5 hours I kept checking my sugar and blood pressure every hour . They were fine . I?m waiting to hear back from my doctor as this is not a listed side affect but I have read about many others having these issues .
Hasn't received the second dose; This spontaneous case was reported by a pharmacist and describes the occurrence of Hasn't received the second dose in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced Hasn't received the second dose. At the time of the report, Hasn't received the second dose had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment information was provided by the reporter.
When I received my first two vaccines I was given a weblink where I was to check in regularly to report symptoms.  I was given no such instruction for the booster shot I received at pharmacy.  Therefore, I thought I should report the following symptoms I have been experiencing since I have had my booster on Saturday 9/25 at 4:30 pm. CST.  9/25 - some minor pain at injection site and a slight headache  9/26 - minor pain at injection site, fatigue, migraine like headache, general body aches, nausea  9/27 - redness and swelling around injection site, slight fatigue, minor headache  9/28 - redness, swelling and hardness in muscle around injection site, slight fatigue  9/29 - continued redness, itching, swelling and hardness in muscle around injection site  While I don?t think any of these side affects to be major or long lasting at this point, I do want to point out that the migraine headache, nausea and injection site reactions (aka COVID Arm) are not symptoms I had from my first two Pfizer shots and I think this may be significant to follow in case there is the potential for multiplying side effects occurring in future booster shot recommendations (like a 2nd, 3rd or more booster).
hypoxemia; BL pulmonary infiltrates; This is a spontaneous report received from a contactable reporter(s) (Physician).  A 55 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administration date 12Feb2021 (Batch/Lot number: unknown) at the age of 54 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "DM2" (unspecified if ongoing); "COVID-19", start date: Dec2020 (not ongoing), notes: diagnosed with mild COVID infection in Dec2020, completely recovered after 1 week. Concomitant medication(s) included: METFORMIN. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: Unknown. Unable to locate or read the details), administration date: 25Jan2021, when the patient was 54 years old, for Covid-19 immunization. The following information was reported: HYPOXIA (hospitalization) with onset Feb2021, outcome "recovering", described as "hypoxemia"; LUNG INFILTRATION (hospitalization) with onset Feb2021, outcome "recovering", described as "BL pulmonary infiltrates". The patient was hospitalized for hypoxia, lung infiltration (hospitalization duration: 5 day(s)). The patient underwent the following laboratory tests and procedures: sars-cov-2 test: unknown result; laboratory test: negative. Therapeutic measures were taken as a result of hypoxia, lung infiltration. Clinical course: Patient diagnosed with mild COVID infection in Dec2020, completely recovered after 1wk. Then received 2 doses BNT162b2 in Jan/Feb2021, 2 weeks after second dose subsequently developed hypoxemia and BL pulmonary infiltrates requiring hospital admission, improved with steroids and treatment for CAP. Infectious workup negative. Sx and radiographic findings gradually resolved over 8wks. She then received a booster vaccination Dec2021. 3d later, developed dyspnea and hypoxemia which progressed over the following week. She was again admitted to hospital with hypoxemia and BL pulmonary infiltrates, again improved with steroids and CAP tx. Concern this may represent a pneumonitis or other inflammatory process related to vaccination given time course and recurrence. The lot number for bnt162b2 was not provided and will be requested during follow up.; Sender's Comments: The causal association of reported events in relation to BNT162B2 cannot be excluded on the basis of temporal relation.   The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate,Linked Report(s) : US-PFIZER INC-202200212386 same patient and drug, different event separated in time
Much Heavier menstrual cycle than normal. It was heavy for 7 days and I experienced painful cramps from Lower abdomen/back to my inner thighs for 3/7 days of the cycle. My normal cycles last 5 days are are light after the first day with light cramping on the first day. This was very out of the ordinary for me as I had no dietary or exercise routine changes, nor did I start taking any medications at this time.
Pt received Anthrax and Flumist vaccine 26 Oct 07 does not known if she is/was pregnant. LMP 19 Oct 07. But is somewhat unsure of LMP dates. EDC based on LMP 19Oct07 is 2Nov07.
She presented to  hospital 8-25-22  + sob, cough, ams  over last few days .   UTI 8/22/22.  Negative home covid  test  8-24-22.  Was      +  covid 8-25-22 at  hospital.  More lethargic and baseline bedridden state.  nonverbal since covid 19 infection March 2022 ( long covid 19)  cxr unremarkable.  oxgen sat 96 percent on room air.   Admitted  treated with Remdesivir for one day  stopped at family request , did not require oxygen supplementation. was algo given  doxy, rocephin and decadron and covid 19 supplements.  Had elevated troponins  likely MI from COVID ( not candidate for cath;  had been on  maximal medical management at home for CAD) was  given heparin drip until trop improved.  She was released  8-30-22  DNR status ,  on comfort measures    Passed away at home    9-3-22.
Information was received from a registered nurse referring to a 5 year old male patient. The patient had no medical history or known drug allergy. At 12 months of age, the patient received M-M-R II and VARIVAX (capture into MARRS# 1607USA000541). On 10-JUN-2016 the patient received 1 dose of PROQUAD (lot # M010477, expired 01-SEP-2017, human serum albumin (HSA)) subcutaneously in the left arm. There was no concomitant therapy. ON 17-JUN-2016 the patient developed a localized rash on the left arm at the injection site. The rash was about 2.5 to 3 inches in diameter and was painful and itchy. The patient had sought medical attention via office visit. No treatment was given for the events. No lab diagnosis was performed. The patient still not recovered from the events at the time of the report. The causality was not reported. This is one of 2 reports for the same patient. Additional information has been requested.
felt "zapping", like an "electric choc throughout the body". She says she "felt like she was being tazzered all over the body", and "brain zaps"; This is a spontaneous report from a contactable physician (sister of the patient). A 45-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot/batch number and expiration date not reported), via an unspecified route of administration on 26Mar2021 at single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. It was reported that yesterday (on 08Apr2021), patient felt "zapping", like an "electric choc throughout the body". She said she felt like she was being tazzered all over the body, and "brain zaps". The outcome of the event was unknown. This reporter was reported as non-serious.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
pt recv vax 28APR93 & 28APR93 pt exp rt arm numbness;approx 36hr later pt recovered; Follow up received 8/01. Allergy to "medications in general". Was vaccinated with the first dose of hepatitis b recombivant IM (lot 605610/1252V). Two hours following vaccination, the patient experienced right arm numbness. Approximately 36 hours later, the patient recovered. No further information is available.
I received my first Moderna booster for COVID-19 on 12/02/2021. On 7/8/2022, I was vacationing with my wife. I began to get body aches, dry cough, sore throat, and malaise. I took a self-test for COVID-19 and got a positive result. We stayed overnight at the campground and left for home on 7/9/2022. When we got home on 7/9/2022, I called my county government to see if I could get any monoclonal antibodies, as they were offering them to those who qualified. I got an appointment to get the antibodies at the county clinic on or around 7/11/2022. After I got the antibodies, I began to feel like I was getting better, as I had fewer body aches. When I woke up on 7/19/2022, though, I felt much worse. My ribs hurt and I had chest tightness. I checked my oxygen level, which was only 88%. I ended up going to an urgent care. By the time I got there, I had a fever and was sweating profusely. They immediately admitted me to the hospital. I underwent chest X-rays because they thought I likely had pneumonia. They then gave me antibiotics to prevent any possible secondary infection that could accompany the pneumonia. They also performed a CT scan on my chest, and that was how they found out that I had three different clusters of emboli in the lungs. They then immediately gave me intravenous heparin. I stayed in the hospital for about 3 more days, during which my blood oxygen levels climbed back up to the mid-90s. After that, they switched me to ELIQUIS and discharged me. They also recommended that I follow up with a hematologist. I went to the hematologist, who performed a genetic blood test and took a bone marrow biopsy. She then diagnosed me with myelofibrosis with myeloproliferative neoplasms. I was then referred to a myelofibrosis specialist, who has been treating me with JAKAFI ever since. I am also in a double-blind clinical study in which I am either taking a placebo or a drug. They also want me to take ELIQUIS for at least 6 months to prevent clotting. I was instructed to wait at least 60 days after the beginning of the clinical trial to get another COVID-19 booster. A few months before I caught COVID-19, I began having hypertension that was resistant to treatment. It was then discovered through blood tests that my right kidney had completely ceased functioning and that it had no blood flowing through it. However, my left kidney is still functioning normally.
Fever over 100F; Chills; Restlessness in legs; Restlessness in Legs/spasms; Back pain; Soreness throughout neck; This is a spontaneous report from a contactable consumer, the patient. A 28-year-old female patient received the BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: Lot Number: UNKNOWN) dose 2 via an unspecified route of administration in the left arm on an10Jul2021 at 10:30 (at the age of 28-years-old) as a dose 2 single for COVID-19 immunisation. Patient had no past medical history and no known allergies to medications, food, or other products. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on an unknown date in May2021 (at the age of 28-years-old) as a dose 1, single for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Jul2021 at 20:00, the patient experienced fever 100 Fahrenheit for the first night after 2nd dose, fever the next day as well. Chills all night after 2nd dose, restlessness in legs/spasms, back pain and soreness throughout neck was continuing into day 3. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient underwent lab tests and procedures which included body temperature was over 100 Fahrenheit on 10Jul2021 (Fever over 100F). The patient did not receive any treatment for the events. The clinical outcome of the events of fever 100F, chills, restlessness in legs/spasms, back pain and soreness neck was recovered with sequelae on an unknown date in Jul2021.  The batch/lot numbers for BNT162b2, were not provided and will be requested during follow up.
After the first shot I ran a low fever that fluctuated between 99 and 101.1 degrees for 10 days.  I did not think to take my temp till the day after the shot.  I had a headache off and on for the 10 days.   I rested, drank plenty of fluids. amped up my vit c intake to 2000mg almost every day and took tylenol when needed for the headache.    After the second shot I ran a fever that fluctuated between 100 and 101.7 within 6 hours of the shot.  The fever lasted from Friday at 10 am until 2 am Sunday morning, about 2 days.  I bundled up in winter PJS a fleece robe and a fleece blanket and broke my fever early Sunday morning.   My right arm was far more painful feeling very bruised for about 2 days. I t is now April 2 and I still have the headache but the fever has not returned.
Narrative:  Patient reported numbness and tingling in right arm and hand where the vaccine was injected. After 5 minutes the symptoms resolved. Patient was observed for 30 minutes and no additional symptoms noted.
Patient became ill and tested PCR positive for Covid > 14 days after the completion of vaccine series
Started as petechiae near toes. Spread into larger red spots on ankles, legs, buttocks, arms, and wrists.  Spread consistently over a period of a week, with some spots growing together into significant bruised and sensitive areas.  Note: This was the first time I received a larger dose due to being over 65 years of age.
My arm is swelling up; third COVID-19 vaccine; This is a spontaneous report from a non-contactable consumer (patient). A patient of unspecified age and gender received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection; lot number and expiry date were not reported) via unspecified route of administration on 20Oct2021 as dose 3 (booster), single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Historical vaccine included BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection; lot number and expiry date were not reported) via unspecified route of administration on unspecified dates at dose 1 and 2, single for COVID-19 immunization. The patient received their third COVID-19 vaccine and reported that the swelling in arm was getting pretty big from an unspecified date. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
7 weeks after my vaccination I tested positive for COVID-19 and experienced the following symptoms: Cough, Ears Congestion, Runny nose, Diarrhea and Fatigue. I took Imodium and Benadryl for treatment. Overall the symptoms lasted for 5 days. It took a full month for me to feel back to normal.
5 minutes following tingling in my lips and tongue.  Later that night my tongue felt thick and the tingling progressed from the tip to the back of by tongue.
2 1/2 cm of redness, induration and warmth on right thigh.
p/vax pt lt thigh was swollen from buttock to lt knee; area warm to touch but not reddened; cool compress applied to area
EMS providers approached by 34 y/o M pt c/o diaphoresis and feeling weak. Pt CAOx4 with a GCS of 15. Pt with normal patent airway with no visible signs of distress. Upon initial assessment, pt found to be diaphoretic. Pt moved to cot and full assessment performed and v/s obtained. P 84 regular, RR 18 non-labored, B/P 120/72, SpO2 98% RA. Pt denied CP, SOB, N/V/D. No other associated symptoms noted. Pt rested for approx 10 mins and stated he felt much better. Pt stated that he thought it might have been an anxiety reaction. Repeat vitals P 77 regular, RR 18 non-labored, B/P 128/P, SpO2 97%. Pt did not want to go to the hospital for eval and stated his wife could come pick him up. Pt informed to call emergency responders or go to the
pt autistic sx escalated & pt dx w/autism;Annual follow-up dated 09/29/00 states that the pt's 1st MMR also had an effect on his development, he continues to function at a developemental age of 2-3 years old even though he is almost 7 years of age.
I experienced mild chest pain briefly several times that evening.  It was unusual in the sense that I had not felt it before, and very mild, such that I did not feel the need to seek medical attention.  I also had some shortness of breath, just like a little tightness in my chest and bronchial passages, like a mild form of bronchitis.  It is 9 days since I received the vaccine and the symptoms listed here have re-ocurred sporadically  several times since.  It is currently 5:27 pm and I had the very mild chest pain this morning, the tightness in my lungs/bronchial passages is very mild but pretty constant.
Headache, Arthralgia & CoughWheeze Narrative: reports 10 hours post injection, arthralgias and spasms in low back and hips, resolved within 12 hours. She reports the next day, 14 hours mild knee pain (no h/o knee pain), completely resolved. 40 hours out developed headache, initially responsive to Tylenol, then stopped being so, kept her awake at night had a cough for three hours while awake last night), and then today she is leaving work early because of 7/10 headache.
About 1/2 hour after injection, started a cough similar to a catch in the throat.  About another hour later had chills.  All went away after 2 hours.
Pt arm is red and warm to touch. Site starts 110mm from top of shoulder/arm. Redness is 75mm vertical and 55mm horizontal.